Skip to content

Clinical Study on the Efficacy of Microsecond-Intensity Pulsed Light (IPL) in the Treatment of Rosacea

Clinical Study on the Efficacy of Microsecond-Intensity Pulsed Light (IPL) in the Treatment of Rosacea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097609
Enrollment
Unknown
Registered
2025-02-21
Start date
2025-03-15
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

IPL treatment group:Microsecond intense pulsed light therapy

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age of 18-65 years old, both sexes; (2) rosacea was diagnosed and the symptoms lasted for more than 6 months; (3) Patients agreed to 6 treatments and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) patients with scar constitution; (2) pregnant and lactating women; (3) patients who received other photoelectric therapy during treatment; (4) those who have been exposed to sunlight in the past month or will be exposed to sunlight soon; (5) using local or systemic drugs to treat rosacea in the past month; (6) combined with photosensitive diseases, autoimmune diseases or serious organic diseases affecting the study.

Design outcomes

Primary

MeasureTime frame
VISIA erythema score;L*a*b value;

Secondary

MeasureTime frame
CEA score;PGA score;

Countries

China

Contacts

Public ContactXiang Wen

West China Hospital, Sichuan University

xiangwen_wcums@163.com+86 28 8542 3319

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026